HSPS and National Disability Insurance Agency

Link copied
Case Copied 78 min read

HSPS and National Disability Insurance Agency [2022] AATA 321 (25 February 2022)

Division:NATIONAL DISABILITY INSURANCE SCHEME DIVISION

File Number(s):      2019/2878

Re:HSPS

APPLICANT

AndNational Disability Insurance Agency

RESPONDENT

DECISION

Tribunal:Mrs J C Kelly, Senior Member

Date:25 February 2022

Place:Sydney

The reviewable decision dated 7 May 2019 is affirmed.

............................................[sgd]............................

Mrs J C Kelly, Senior Member

CATCHWORDS

NATIONAL DISABILITY INSURANCE SCHEME - access to the scheme – whether applicant meets disability requirements – whether diagnosis of ASD was appropriately made – where applicant’s fibromyalgia, osteoarthritis and / or bilateral epicondylitis are permanent under s 24(1)(b) – whether Applicant’s conditions result in substantially reduced functional capacity to undertake, or psychosocial functioning in undertaking, any one or more of the activities in s 24(1)(c) – s 24(1)(c) criteria not met  – where provision of early intervention supports is not likely to reduce the applicant’s future needs for supports – decision affirmed

LEGISLATION

National Insurance Scheme Act 2013 (Cth) ss 21, 24, 25

CASES

McFarlane and National Disability Insurance Agency [2018] AATA 4727

Mulligan and NDIA [2014] AATA 374

Mulligan v National Disability Insurance Agency [2015] FCA 544

SECONDARY MATERIALS

Access to the NDIS Operational Guideline

National Disability Insurance Scheme (Becoming a Participant) Rules 2016 (Cth)

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.)

REASONS FOR DECISION

Mrs J C Kelly, Senior Member

25 February 2022

Introduction

  1. On 9 January 2019, the Applicant, HSPS, made a request to the National Disability Insurance Agency (the Agency) to access the National Disability Insurance Scheme (the NDIS). 

  2. Her current treating clinical psychologist/clinical neuropsychologist (the treating psychologist) filled out “Section 2: Details of the person’s impairment/s” in the Access Request – Supporting Evidence Form dated 11 April 2019.  She listed “Autism Spectrum Disorder – Level 1” as the Applicant’s primary impairment, which was lifelong, and “another impairment”, fibromyalgia, diagnosed by a rheumatologist in 2016.  The treating psychologist did not tick any of the boxes in response to the question “Are there early intervention supports that are likely to benefit the person by reducing their future needs for supports?”.  She wrote in the adjoining panel under the heading “Details of recommended early intervention supports” “(the Applicant) is an adult”.  She ticked a box indicating that she attached a “Vineland Adaptive Behaviour Scale (Vineland-II)”. 

  3. The access request was refused because the Applicant did not meet the disability requirements in s 24 of the National Insurance Scheme Act 2013 (Cth) (the Act).  She applied for an internal review of that decision.  On 7 May 2019, the internal reviewer confirmed the refusal decision.  The Tribunal is reviewing that decision.

    The law

  4. The access criteria are set out in s 21(1):

    When a person meets the access criteria

    (1)  A person meets the access criteria if:

    (a)  the CEO is satisfied that the person meets the age requirements (see section 22); and

    (b)  the CEO is satisfied that, at the time of considering the request, the person meets the residence…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read HSPS and National Disability Insurance Agency and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2022] AATA 321
Decision Date

CaseChat Overview and Summary

This matter concerned an application for review of a decision by the National Disability Insurance Agency (NDIA) to refuse access to the National Disability Insurance Scheme. The applicant sought access to the scheme on the basis of Autism Spectrum Disorder (ASD), fibromyalgia, osteoarthritis, and bilateral epicondylitis. The NDIA had determined that the applicant did not meet the disability requirements for access, specifically that their conditions were not permanent and did not result in a substantially reduced functional capacity.

The Tribunal was required to determine whether the applicant's conditions, namely ASD, fibromyalgia, osteoarthritis, and bilateral epicondylitis, were permanent impairments under section 24(1)(b) of the relevant legislation. Furthermore, the Tribunal had to consider whether these conditions resulted in a substantially reduced functional capacity to undertake, or psychosocial functioning in undertaking, any one or more of the activities listed in section 24(1)(c) of the legislation.

The Tribunal considered the evidence regarding the diagnosis of ASD, noting the treating psychologist's reliance on behavioural observation and historical information. While the psychologist acknowledged the preference for corroborative information from relatives, she maintained that such information was not essential for diagnosis, despite an initial file note indicating she could not fully verify the ASD diagnosis without collateral information. The Tribunal also examined the permanence of the applicant's other conditions. Expert evidence indicated that fibromyalgia, while often chronic, is responsive to treatment and can vary in intensity, leading to the conclusion that it could not be regarded as permanent in the same way as other health conditions.

The Tribunal affirmed the NDIA's decision. It found that the applicant's conditions, particularly fibromyalgia, did not meet the criteria for permanence as defined by the legislation. Consequently, the Tribunal concluded that the applicant did not satisfy the requirements for access to the National Disability Insurance Scheme.

Background

Background to the litigation

The case of HSPS and the National Disability Insurance Agency involves the Applicant's application for access to the National Disability Insurance Scheme (NDIS). The Applicant contends that he meets the disability requirements under the NDIS Act, primarily due to his diagnosis of Autism Spectrum Disorder (ASD) and the permanency of his other medical conditions: fibromyalgia, osteoarthritis, and bilateral epicondylitis. The National Disability Insurance Agency (NDIA) challenged the Applicant's claim on several grounds, questioning the appropriateness of the ASD diagnosis and the permanency of the other conditions.

The Applicant's diagnosis of ASD was a central point of contention in the case. The treating psychologist diagnosed the Applicant with ASD, relying on behavioural observation and the Applicant's self-reported symptoms. However, the NDIA argued that the diagnosis was not appropriately made as there was a lack of corroborative historical information from people who knew the Applicant as a child, which is generally considered essential for confirming a diagnosis of ASD in adults. The treating psychologist maintained her diagnosis, asserting that while such corroboration is preferable, it is not essential for making a diagnosis. The psychologist had attempted to obtain historical information by sending a questionnaire to the Applicant's aunt, but efforts to contact other relatives were incomplete.

In addition to the ASD diagnosis, the permanency of the Applicant's other conditions was also scrutinized. The NDIA questioned whether fibromyalgia, osteoarthritis, and bilateral epicondylitis were permanent impairments under section 24(1)(b) of the NDIS Act. Medical evidence suggested that these conditions are not necessarily permanent. For instance, the treating GP noted that the Applicant's fibromyalgia did not require further treatment to establish permanency, and evidence indicated that the condition is responsive to treatment and varies in intensity over time. Similarly, the other conditions were assessed for their permanency, with findings suggesting that they do not meet the criteria for being considered permanent impairments.

The case also explored whether the Applicant's conditions resulted in substantially reduced functional capacity or psychosocial functioning in undertaking activities as outlined in section 24(1)(c) of the NDIS Act. The evidence indicated that these criteria were not met, and it was argued that the provision of early intervention supports was not likely to reduce the Applicant's future needs for supports. These findings played a role in the overall assessment of the Applicant's eligibility for the NDIS.

The matter before the court is an appeal by the Applicant, HSPS, against a decision of the National Disability Insurance Agency (NDIA) that she does not meet the disability requirements under the National Disability Insurance Scheme (NDIS). The appeal was heard following a hearing at first instance before the Administrative Appeals Tribunal (AAT), where the NDIA's decision was affirmed. The Applicant, represented by counsel, challenges the AAT's findings on several grounds, including the determination that her fibromyalgia, osteoarthritis, and bilateral epicondylitis are not permanent impairments under section 24(1)(b) of the NDIS Act and that her conditions do not result in substantially reduced functional capacity to undertake, or psychosocial functioning in undertaking, any one or more of the activities in section 24(1)(c). The Applicant also contests the AAT's finding that the provision of early intervention supports is not likely to reduce her future needs for supports. Throughout the proceedings, the Applicant has sought to substantiate her claims with medical evidence and expert opinions, while the NDIA has defended its decision by relying on its own assessments and the absence of corroborative historical information for the diagnosis of Autism Spectrum Disorder (ASD).

Prior to the hearing, the Applicant filed several applications, including requests for additional time to file evidence and for the production of documents from the NDIA. The NDIA opposed these applications, arguing that the Applicant's requests were not justified and would unduly delay the proceedings. The tribunal considered these applications and made interlocutory orders that balanced the need for procedural fairness with the efficient administration of justice. During the hearing, the tribunal heard extensive evidence from both parties, including medical reports, expert testimonies, and cross-examinations. The focus of the arguments was on the permanency of the Applicant's conditions, the impact of these conditions on her functional capacity, and the appropriateness of the NDIA's assessment process. The tribunal also examined the relevance and weight of historical corroborative information in the diagnosis of ASD, as argued by the NDIA.

Decision

Reasons for decision

The treating GP’s opinion was that the Applicant’s fibromyalgia does not require any further treatment for permanency to be established. The evidence does not suggest that he was aware of the Applicant’s use of cannabis. Conclusion The focus of evidence and the Respondent’s submissions on this issue was on fibromyalgia because pain overlaps with both bilateral epicondylitis and osteoarthritis. Having addressed only fibromylgia during submissions, counsel for the Respondent concluded:That’s why we say you should not find that fibromyalgia or the other two conditions are permanent. I accept that endone is ineffective in treating fibromyalgia and can increase or enhance the pain experienced by the sufferer of fibromyalgia, including at lower dosages, although as Professor Cameron wrote, the chance of problems occurring with such dosage is clearly less than with higher dosages. I also accept that cannabis is not recommended for chronic pain. In one of his 3 January 2018 report, Professor Cameron wrote the following:1. What is the aetiology of fibromyalgia?Fibromyalgia is a condition of generalized body pain without a known cause or cure (Fitzcharles et al 2013). Its aetiology is therefore unknown. It is hypothesised that certain people are more likely to experience chronic widespread pain. This is due to a combination of environmental and genetic influences (Clauw et al 2014). It is definitely more prevalent in women and men in a ratio of 2:1 (Clauw 2014). (Emphasis added)…5. If this condition results from an impairment, what is the likelihood that this impairment will be permanent?It is noted that impairment is, or is likely to be, permanent only if there are no known, available and appropriate evidence based treatments that would be likely to remedy (i.e. cure or substantially relieve) the impairment – as shown in Rule 5.4 of the Rules. (Emphasis added).Fibromyalgia cannot be regarded as permanent because it is responsive to treatment (see above) and is likely to vary in intensity at different times due to a variety of factors.A well conducted study has shown that most people continue to experience symptoms over a long period but approximately 25% improved in the long term (Walitt et al 2011). However, severity worsened in about 40%. Thus there is considerable variability in prognosis and responses to treatment. It should be noted that this study was conducted in patients of American rheumatologists and may represent a cohort of people with more severe fibromyalgia than those treated in primary healthcare settings.Fibromyalgia cannot be considered permanent in the same way as many health conditions, because the underlying impairment is pain and this varies considerably over time and in response to treatments and life situations[15]. [15] TB Tab 15, pp 64-65. Dr Guymer’s evidence about permanence was:What is the likelihood of permanence of this condition? NB Permanence means no recovery; lifelong impairment and associated disability? (Emphasis added.)·Once fibromyalgia develops, the person tends always to have varying levels of increased central sensitivity and impairment·The intensity of symptoms will often fluctuate over time, influenced by effectiveness of treatments, and ongoing physical or psychological stressors·The sensitivity symptoms can be controlled to different extents depending on individual response to therapy, however there are often episodic flares.[16][16] TB Tab 17, p 77.

Ratio Decidendi

Legal Principle Established

A 9 August 2019 clinical note records that the academic institution had accepted that the incident had occurred and wanted to offer financial compensation. Corroboration by relatives The Respondent criticised the treating psychologist’s diagnosis of ASD because of the lack of corroborative historical information to support the diagnosis. It relied on an article entitled Identifying the lost generation of adults with autism spectrum conditions[9] which included the following: Being neuro developmental, characteristics of autism spectrum conditions have, by definition, to be present in early childhood. Therefore interviewing informants who can provide reliable and valid information about the patient’s developmental history is essential to confirm a diagnosis, irrespective of the age of the patient at the time of assessment. (Reference omitted). For adults, the patient’s childhood care givers might no longer be alive or in contact, but other possible suitable informants are older siblings, relatives, or neighbours who knew the patient well as a child. The quality of the informant’s recall might not be detailed or might be inaccurate due to the long time lag. The clinician’s nonleading questions and use of important life events to define target time windows can help informants to retrieve the best possible information. (Emphasis added.)[9] Lai, M. C., & Baron-Cohen, S. (2015). Identifying the lost generation of adults with autism spectrum conditions. The Lancet Psychiatry, 2(11), 1013–1027. Contained in Tender Bundle (TB) p 34. The treating psychologist agreed with the content of that paragraph except that having such information was essential to confirm a diagnosis. She said that it was preferable. On the second day of giving evidence, she said that she did not agree that a diagnosis of ASD cannot be verified if there is a lack of independent corroboration from people who knew the adult as a child. She was cross-examined about her file note for a session on 21 May 2018 that the Applicant felt strongly that she was on the autism spectrum, and having run through various tests wrote:Indicative of likely ASD, however did not have collateral information, so cannot fully verify this. She said that the note was a reflection of her discussion with the Applicant on that day. She maintained her position. ASD is a lifelong condition. Clients present with the symptoms. Behavioural observation, as well as historical information is very important for diagnosis. She stood by her diagnosis. On the first day the treating psychologist was cross-examined, her clinical notes were not available to her or to the Tribunal or the parties. Her recollection was that she had given a questionnaire to the Applicant’s brother. Once the clinical notes were provided, what she had done became clear. She had given a written relatives questionnaire to the Applicant’s aunt. Although her file note stated that the Applicant had also consented to one going to a cousin, that was not done. She did not recall that reference. Her file note indicated that she did not try to get consent to send it to the Applicant’s brother.